DGAP-News: Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics
PRROTECT leverages a comprehensive set of novel projects and technologies to be better prepared for and respond faster to viral pandemics of the future.
DGAP-News: Evotec SE / Key word(s): Miscellaneous Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics 15.06.2021 / 07:30 The issuer is solely responsible for the content of this announcement.
Dr Werner Lanthaler, Chief Executive Officer of Evotec SE, commented: "COVID-19 has taught us that any pandemic response is incomplete without effective therapeutics. Preparing for the next pandemic rather than reacting to an outbreak can accelerate the response time until effective therapeutics are available dramatically. We want to see the launch of PRROTECT as an open invitation to all interested network partners globally to join forces now, so that no generation has to experience the level of unpreparedness that we all suffered from in the last 2 years ever again."
15.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Evotec SE |
Manfred Eigen Campus / Essener Bogen 7 | |
22419 Hamburg | |
Germany | |
Phone: | +49 (0)40 560 81-0 |
Fax: | +49 (0)40 560 81-222 |
E-mail: | [email protected] |
Internet: | www.evotec.com |
ISIN: | DE0005664809 |
WKN: | 566480 |
Indices: | MDAX, TecDAX |
Listed: | Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1207885 |
End of News | DGAP News Service |
|
1207885 15.06.2021